X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (168) 168
hematology (151) 151
female (90) 90
male (89) 89
index medicus (85) 85
adult (76) 76
middle aged (53) 53
mutation (45) 45
von willebrand factor (41) 41
von willebrand disease (36) 36
peripheral vascular disease (35) 35
aged (32) 32
adolescent (31) 31
child (29) 29
von willebrand diseases - genetics (28) 28
inherited bleeding disorders (26) 26
factor-viii (25) 25
hemophilia (25) 25
von willebrand factor - genetics (25) 25
desmopressin (24) 24
diagnosis (23) 23
factor viii - therapeutic use (20) 20
italy (20) 20
phenotype (20) 20
von willebrand diseases - blood (20) 20
deamino arginine vasopressin - therapeutic use (19) 19
factor viii (19) 19
genotype (19) 19
heterozygote (19) 19
risk factors (19) 19
von willebrand diseases - drug therapy (19) 19
von willebrand factor - analysis (19) 19
abridged index medicus (18) 18
prophylaxis (18) 18
thrombosis (18) 18
bleeding (17) 17
identification (17) 17
von willebrand diseases - diagnosis (16) 16
von willebrand factor - metabolism (16) 16
hemic and lymphatic diseases (15) 15
management (15) 15
pedigree (15) 15
point mutation (15) 15
pregnancy (15) 15
bleeding time (14) 14
child, preschool (14) 14
dna mutational analysis (14) 14
prevalence (14) 14
venous thromboembolism (13) 13
aged, 80 and over (12) 12
blood coagulation factor viii (12) 12
congenital, hereditary, and neonatal diseases and abnormalities (12) 12
families (12) 12
disease (11) 11
hemophilia a - drug therapy (11) 11
hemorrhage - etiology (11) 11
mutation, missense (11) 11
prospective studies (11) 11
children (10) 10
factor v - genetics (10) 10
inherited thrombophilia (10) 10
italy - epidemiology (10) 10
multicenter (10) 10
plasma (10) 10
retrospective studies (10) 10
severity of illness index (10) 10
venous thrombosis (10) 10
von willebrand factor - therapeutic use (10) 10
alleles (9) 9
cohort studies (9) 9
factor viii - analysis (9) 9
factor xi deficiency - genetics (9) 9
gene (9) 9
hemophilia a (9) 9
homozygote (9) 9
infant (9) 9
inhibitors (9) 9
molecular sequence data (9) 9
original article (9) 9
risk (9) 9
thrombophilia (9) 9
treatment outcome (9) 9
young adult (9) 9
animals (8) 8
blood platelets - metabolism (8) 8
clinical medicine (8) 8
ddavp (8) 8
disorders (8) 8
fibrinogen (8) 8
follow-up studies (8) 8
gene mutation (8) 8
genetic aspects (8) 8
hemophilia a - therapy (8) 8
hemorrhage - prevention & control (8) 8
hemostatics - therapeutic use (8) 8
infant, newborn (8) 8
letters to the editor (8) 8
medical and health sciences (8) 8
medicin och hälsovetenskap (8) 8
medicine (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Haematologica, ISSN 0390-6078, 01/2018, Volume 103, Issue 2, pp. 195 - 196
Journal Article
Expert review of hematology, 08/2018, Volume 11, Issue 8, p. 673
The health benefits of prophylactic dosing regimens for clotting factor therapy in patients with hemophilia include reduced joint damage and improved quality... 
Journal Article
Expert Review of Hematology, ISSN 1747-4086, 08/2018, Volume 11, Issue 8, pp. 673 - 683
Introduction: The health benefits of prophylactic dosing regimens for clotting factor therapy in patients with hemophilia include reduced joint damage and... 
Factor IX | coagulation factor replacement therapies | long-acting | prophylaxis | hemophilia B | FC FUSION PROTEIN | FACTOR-VIII | ON-DEMAND TREATMENT | NONACOG BETA PEGOL | COAGULATION-FACTOR-IX | MODERATELY SEVERE | RECOMBINANT FACTOR-IX | GLYCOPEGYLATED FACTOR-IX | QUALITY-OF-LIFE | HEMATOLOGY | PREVIOUSLY TREATED PATIENTS
Journal Article
Mediterranean Journal of Hematology and Infectious Diseases, ISSN 2035-3006, 2013, Volume 5, Issue 1, p. e2013052
Delivery in von Willebrand disease (VWD) represents a significant hemostatic challenge because of the variable pattern of changes observed during pregnancy of... 
Journal Article
Farmeconomia. Health economics and therapeutic pathways, ISSN 2240-256X, 06/2016, Volume 17, Issue 2, pp. 59 - 65
BACKGROUND: Replacement therapy with von Willebrand factor (VWF)/factor VIII (FVIII) concentrates represents an effective approach for patients with von... 
Journal Article
European Journal of Haematology, ISSN 0902-4441, 08/2019, Volume 103, Issue 2, pp. 73 - 79
Journal Article
Clinical Cases in Mineral and Bone Metabolism, ISSN 1724-8914, 05/2015, Volume 12, Issue 2, pp. 157 - 164
Gaucher disease is a rare multi-systemic metabolic disorder caused by the inherited deficiency of the lysosomal enzyme β-glucocerebrosidase, which leads to the... 
Glucocerebroside | Storage burden | Activated macrophage | Gaucher disease | Enzyme replacement therapy | activated macrophage | storage burden | enzyme replacement therapy | glucocerebroside | Mini-Review
Journal Article
Current Opinion in Hematology, ISSN 1065-6251, 09/2013, Volume 20, Issue 5, pp. 424 - 429
Journal Article
Mediterranean Journal of Hematology and Infectious Diseases, ISSN 2035-3006, 07/2013, Volume 5, Issue 1, pp. e2013052 - e2013052
Delivery in von Willebrand disease (VWD) represents a significant hemostatic challenge because of the variable pattern of changes observed during pregnancy of... 
Bleeding disorders
Journal Article
American Journal of Hematology, ISSN 0361-8609, 06/2014, Volume 89, Issue 6, pp. 569 - 570
Journal Article
HAEMATOLOGICA, ISSN 0390-6078, 08/2019, Volume 104, Issue 9, pp. 1702 - 1709
Journal Article
Expert opinion on drug metabolism & toxicology, 12/2017
The prevention of bleeding by prophylactic factor replacement is the recommended approach for the treatment of severe hemophilia. Prophylaxis should be... 
Journal Article
Blood transfusion = Trasfusione del sangue, ISSN 1723-2007, 12/2015, p. s527
Journal Article
Blood, ISSN 0006-4971, 2014, Volume 124, Issue 15, pp. 2333 - 2336
The risk for inhibitor development in mild hemophilia A (factor VIII levels between 5 and 40 U/dL) is larger than previously anticipated, continues throughout... 
MODERATE HEMOPHILIA | RESPONSIVENESS | FACTOR-VIII INHIBITORS | MUTATION | DISEASE | DISORDERS | DESMOPRESSIN DDAVP | EXPERIENCE | MORTALITY-RATES | HEMATOLOGY | CHILDREN | Animals | Hemophilia A - immunology | Humans | Risk Factors | Antibodies - immunology | Hemophilia A - prevention & control | Hemophilia A - drug therapy | Spotlight | 100
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.